Quabodepistat

Quabodepistat · Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Quabodepistat, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis [Phase 3]